Skip Navigation


Europace Advance Access originally published online on April 20, 2007
Europace 2007 9(8):702-705; doi:10.1093/europace/eum049
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
9/8/702    most recent
eum049v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bortone, A.
Right arrow Articles by Pasquié, J.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bortone, A.
Right arrow Articles by Pasquié, J.-L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2007. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

CLINICAL ELECTROPHYSIOLOGY

Intermittent fasciculoventricular pathway: ECG and electrophysiologic findings, clinical implications

Agustín Bortone*, Florence Leclercq, Robert Grolleau-Raoux and Jean-Luc Pasquié

CHU Montpellier, Service de Cardiologie A, Clinique de Maladies du Cœur et des Vaisseaux, Hôpital Arnaud de Villeneuve, Centre Hospitalo-Universitaire, 371, avenue du Doyen Gaston Giraud, 34295 Montpellier Cedex 5, France

Although fasciculoventricular (FV) pathways never participate into tachycardia circuits, they give rise to ventricular pre-excitation of variable magnitude which can be source of ECG misinterpretation when associated to other supraventricular rhythm disorders. We report an intermittent FV pathway coincidentally unmasked during an electrophysiologic study performed for a symptomatic supraventricular tachycardia (atrial tachycardia). The clinical context, ECG and EP findings, and therapeutic options are described. Fasciculoventricular pathways need no medical or ablative treatment, thus their positive and differential diagnosis must be clearly assessed.

Key Words: Ventricular pre-excitation, Mahaim fibres, Intermittent fasciculoventricular pathway, Atrial tachycardia

* Corresponding author: Tel: +33 467 33 62 17; Fax: +33 467 33 62 18. E-mail address: agubene{at}hotmail.com

Manuscript submitted 6 November 2006. Accepted after revision 3 March 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.